Oruka Therapeutics Inc. Common Stock vs Rackspace Technology Inc. Common Stock — how do they compare? Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.18B), while Rackspace Technology Inc. Common Stock trades at $3.08 (market cap $925.19M). The key difference: Oruka Therapeutics Inc. Common Stock is far larger — about 5.6× Rackspace Technology Inc. Common Stock's market cap, and Oruka Therapeutics Inc. Common Stock is trading nearer its 52-week high, Rackspace Technology Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Oruka Therapeutics Inc. Common Stock for 0 Days and Rackspace Technology Inc. Common Stock for 0 Days on average.
| ORKA | RXT | |
|---|---|---|
Market Cap | $5.18B | $925.19M |
Volume | 490,798 | 2,631,364 |
Sector | Health | Technology |
52-Week High | $113.08 | $7.53 |
52-Week Low | $26.19 | $0.41 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $4.31B | $4.09B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →Rackspace Technology, Inc. provides managed multicloud and hybrid cloud services, helping organizations design, operate, and support workloads across AWS, Microsoft Azure, Google Cloud, and private infrastructure.
Read more on RXT →